Compounds > 1,4,7-triazacyclononane-n,n',n''-triacetic acid
Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and Lymphoma, B-Cell, Marginal Zone

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cheng, Z; Kou, Y; Yao, Z1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Hepatic Lesion of Mucosa-Associated Lymphoid Tissue Lymphoma Revealed by Al18F-NOTA-FAPI-04 PET/CT.
    Clinical nuclear medicine, 2022, Jan-01, Volume: 47, Issue:1

    Topics: Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines

2022